To assess the safety and feasibility of Transcatheter Aortic Valve Replacement (TAVR) with commercially available bioprostheses in patients with severe, symptomatic aortic stenosis (AS) who are low-risk (STS score ≤3%) for surgical aortic valve replacement (SAVR).
**Sutter Medical Center Sacramento currently enrolling to Bicuspid Aortic Valve arm of study only**
Location: SIMR (Sacramento/Valley Area)
Please contact email@example.com about Study MedStar Low Risk TAVRView study details on ClinicalTrials.gov
Recruiting to Bicuspid Aortic Valve arm only.
March 01, 2017